V. Kolek (Olomouc, Czech Republic), A. Browatzki (Copenhagen, Denmark), H. Andreasen (Copenhagen Nv, Denmark), B. Brockway (Dunedin, New Zealand)
Efficacy of administration of 0.02% solution of decamethoxine via nebulizer in patients with infectious exacerbations of COPD
O. Denysova, R. Sukhin (Kyiv, Ukraine)
|   |
How does aerodynamic peculiarities of upper airways influence heart rhythm in severe COPD patients
Y. Feshchenko, L. Iashyna, V. Ignatieva, S. Moskalenko, I. Zvol, I. Chumak (Kiev, Ukraine)
| |
Interrelation between some indices of polysomnography and nasal flows in severe COPD patients
L. Iashyna, Y. Feshchenko, V. Ignatieva, S. Ishyk, N. Kramarskya, N. Dyachenko (Kiev, Ukraine)
| |
Clinical status and systemic inflammation in COPD patients treated by magnetic stimulation of paravertebral ganglia
N. Sanina, T. Pertseva, S. Panina (Dnipropetrovs'k, Ukraine)
| |
Diagnosis confirmation and staging in patients hospitalized with diagnosis of COPD in a general hospital with adequate resources
I. Godoy, A. P. Delgallo Merli, D. Maciel Calvacnti Rosa, L. Vaz de Arruda Silveira, I. Godoy (Botucatu, Bauru, Brazil)
| |
Comorbidity in patients with COPD in Russia
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
The influence of NIV on the pulse wave velocity in patients with the exacerbation of COPD
S. Lukyanov, V. Gorbunov, S. Alexeev, M. Lazutkin, T. Aksenova (Chita, Russian Federation)
| |
Some gender features of the chronic obstructive pulmonary disease
N. Lareva, E. Luzina (Chita, Russian Federation)
| |
NT-proBNP in assessment of pulmonary hypertension in COPD patients
M. Grabicki, H. Batura-Gabryel, B. Kuznar-Kaminska, B. Brajer-Luftmann (Poznan, Poland)
| |
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
B. Kuznar-Kaminska, M. Grabicki, B. Brajer-Luftmann, H. Batura-Gabryel (Poznan, Poland)
| |
Effect of short-acting bronchodilators (BDs) on the severity of respiratory muscle (RM) strength in COPD patients (pts)
B. Basina, T. Pertseva, L. Konopkina (Dnipropetrovsk, Ukraine)
| |
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype
G. Camiciottoli, F. Bigazzi, V. Luzzi, E. Torricelli, M. Vannini, A. Garcea, L. Corsi, M. Paoletti, L. Cestelli, M. Pistolesi (Florence, Italy)
| |
Sputum matrix metalloproteinase-9 is associated with emphysema on computed tomography in COPD
R. Chaudhuri, C. McSharry, J. Brady, C. Grierson, C. M. Messow, M. Spears, K. Nocka, W. MacNee, M. Connell, J. Murchison, M. Sproule, D. Miller, N. C. Thomson (Glasgow, Dundee, Edinburgh, United Kingdom; Cambridge MA & Collegeville, PA, United States Of America)
| |
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
D. Korzybski, A. Nowinski, B. Broniarek-Samson, D. Gorecka (Warsaw, Poland)
| |
COPD exacerbation admissions: Analysis of demographics and mortality
F. Tsou, D. Piñeiro, H. Di Fonzo, S. Ariel, M. E. Mariano (Ciudad de Buenos Aires, Argentina)
| |
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
V. Abdullayev, G. Aliyeva (Baku, Azerbaijan)
| |
Time course of daily activity at COPD exacerbation
A. AlAhmari, A. Patel, B. Kowlessar, A. Mackay, R. Singh, J. Allinson, J. Wedzicha, G. Donaldson (London, United Kingdom)
| |
Lung cancer in patient with chronic obstructive pulmonary disease (comorbidity by smokers-a cumulative effect of exogenic and endogenic factors? Part II)
Z. Iankova, R. Ivancheva, V. Youroukova, F. Sterev, S. Kartev, D. Kostadinov (Plovdiv, Sofia, Bulgaria)
| |
A global survey conducted to determine frequency of exacerbations in COPD patients
J. Gispert, I. S. Chiang, V. Brandi, N. Leslie (Madrid, Spain; San Diego, Miami, United States Of America; Edinburgh, United Kingdom)
| |
Pneumococcal vaccination: Effects on exacerbation of COPD
M. Alves, F. Lundgren, C. Caribé, I. Secundo, S. Marrocos, J. Accioly, M. Lima (Recife, Brazil)
| |